CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

FDA Drugs (New Approvals & NDA)
Original article

Phase 1 Investigational New Drug (IND) Navigator

Phase 1Neutral
AI Analysis

Summary

FDA publishes Phase 1 IND Navigator providing tools, guidance, and regulatory expertise for preparing and submitting Investigational New Drug applications.

Importance:1/10
Sentiment:
0.00
regulatory_guidanceIND_applicationPhase_1

Read the original article

Published by FDA Drugs (New Approvals & NDA) on October 9, 2026 5:54 PM

Read Original